Clinical trials · New York, NY
Infections clinical trials in New York
We’re tracking 117 recruiting infections studies with a site in or near New York — including Phase 2, Phase 2/Phase 3, Phase 3 and Phase 4 studies, each written for real people, not researchers.
Recruiting studies near New York
- NCT07022678RecruitingPhase 3
Xylitol dental wipes to reduce infection risk in childhood leukemia
This trial tests whether using xylitol dental wipes can lower the risk of bloodstream infections in children with acute myeloid leukemia (AML) who are receiving chemotherapy. If you or your child have AML and will have at least two cycles of chemo that include cytarabine, this study may help reduce infection risk.
The Bronx, New YorkAges 1–25 - NCT07454915RecruitingPhase 2
PVX4 vaccine for HPV16-related cervical dysplasia
This trial tests a new vaccine called PVX4 for women with HPV16-related cervical dysplasia. It aims to see if the vaccine can help clear the high-risk HPV infection and the abnormal cells on the cervix.
The Bronx, New YorkAges 18–60 - NCT07293559Recruiting
Understanding infant feeding choices in women with HIV
This study looks at how women with HIV decide whether to breastfeed, and what support they get from healthcare providers and family. It aims to learn about their experiences and needs.
The Bronx, New YorkAges Any age - NCT06714864RecruitingPhase 4
Preventing catheter infections in children on dialysis
This study tests a liquid that is put into the dialysis catheter after each session to prevent infections that can happen through the catheter. It is designed for children up to age 18 who need hemodialysis through a catheter.
Hackensack, New JerseyAges Up to 17 years - NCT07284563RecruitingPhase 2
Ultra-low dose bone scan imaging study
This trial tests a much smaller amount of radiation during a PET scan to see if it can still show bone issues clearly. You might join if you need a bone scan and want to try a lower radiation approach.
Englewood, New JerseyAges 18–120 - NCT01905709Recruiting
Fecal transplant to treat recurring C. difficile infection
This trial studies using a fecal microbiota transplant (FMT)—healthy gut bacteria moved from a screened donor—to help treat recurring or hard-to-control C. difficile infection. It may help restore a healthier gut environment when standard treatments keep failing or the infection returns.
Englewood, New JerseyAges 18 years+ - NCT07393594Enrolling by invitation
Tracer study for kidney transplant monitoring
This study looks at a new blood test to help monitor the health of your transplanted kidney and check for early signs of rejection. The test will be done as part of your usual care after a kidney transplant.
Livingston, New JerseyAges 18 years+ - NCT06261736Recruiting
Antibiotics before urethral bulking to prevent infection
This trial tests whether taking antibiotics before a urethral bulking procedure can help prevent infections. It is for people who are scheduled for this procedure and have no history of recurrent UTIs or bladder problems.
Morristown, New JerseyAges 18 years+ - NCT06810687Recruiting
Methenamine vs. antibiotics to prevent UTIs after sling surgery
This study compares a non-antibiotic medicine (methenamine) to antibiotics for preventing urinary tract infections after a common incontinence surgery (mid-urethral sling). It may help people avoid antibiotics and their side effects.
Morristown, New JerseyAges 18–100 - NCT07225972RecruitingPhase 3
Immune cells from a family donor for stubborn virus infections after stem cell transplant
This trial is testing whether giving special immune cells from a family donor (called CTLs) along with regular antiviral medicine is better than regular medicine alone for people who have a stubborn adenovirus or cytomegalovirus infection after a stem cell transplant.
Valhalla, New YorkAges 1 day–30 years - NCT03266640RecruitingPhase 2
CMV cell therapy for difficult-to-treat viral infection
This trial tests an immune cell treatment (CMV-specific cytotoxic T cells) for people with a CMV infection that is not improving despite standard antivirals, or who cannot tolerate them. If eligible, the treatment aims to help the body control the virus after transplant-related immune problems.
Valhalla, New YorkAges 1 month–79 years - NCT03266653RecruitingPhase 2
T-cell therapy for stubborn Epstein-Barr virus after transplants
This trial tests an immune therapy made from EBV-targeted T-cells to treat EBV infections that do not improve with standard anti-viral medicines. It may help by strengthening the body’s ability to fight EBV after certain transplants or immune problems.
Valhalla, New YorkAges 1 month–79 years - NCT05711667RecruitingPhase 3
Letermovir to prevent CMV after stem cell transplant in kids
This trial tests whether the medicine letermovir can prevent a common virus (CMV) from coming back after an allogeneic stem cell transplant in children. It may help lower the risk of CMV infection during the vulnerable period right after transplant.
Valhalla, New YorkAges 2–18 - NCT05564598RecruitingPhase 2
Trial of immune therapy for newborns with congenital CMV
This Phase 2 trial tests an immune treatment made from donor T-cells to help the body fight congenital CMV infection in newborns. It may be an option if your baby is very young, has evidence of CMV infection, and meets specific blood, kidney, and liver safety limits.
Valhalla, New YorkAges birth–3 weeks - NCT07513285RecruitingPhase 2
Ibezapolstat pill for recurrent C. difficile infection
This trial tests a new oral antibiotic called ibezapolstat to treat recurrent C. difficile infection (CDI)—a serious diarrheal illness caused by bacteria in your gut. The study focuses on patients who have had multiple CDI episodes and may benefit from a different treatment approach.
Massapequa, New YorkAges 18–90 - NCT06416150Recruiting
Text message support for cervical cancer screening
This study aims to reduce gaps in cervical cancer care by using text messages to help people who have been referred for a colposcopy. If you qualify, you will receive text reminders and support to make sure you get the follow-up you need.
New Brunswick, New JerseyAges 18–90 - NCT06080698Recruiting
Oral antibiotics for bloodstream infection trial
This trial tests whether switching from IV to oral antibiotics is just as effective for treating Gram-negative bloodstream infections. If you qualify, you may receive either continued IV antibiotics or switch to pills, with follow-up on your recovery and quality of life.
New Brunswick, New JerseyAges 18 years+ - NCT04821154Recruiting
Testing outcomes after revision knee replacement with a Persona system
This study looks at how well a specific revision knee replacement system (the Persona system) works after earlier knee problems or surgeries. You may be eligible if you need a revision knee and can follow follow-up care instructions; the trial also checks for certain infection, bone, and health-safety factors.
Chester, New JerseyAges 18 years+ - NCT07266831RecruitingPhase 2/Phase 3
New HIV treatment for people not yet on medication
This study tests a new combination medicine for people with HIV who have never taken treatment. It aims to see if it is safe and helps reduce the amount of virus in the blood.
Hillsborough, New JerseyAges 18 years+ - NCT05471908Recruiting
Compare automatic versus as-needed follow-up after common infections
This study compares two ways of scheduling a check-up after a child is hospitalized: an automatic visit or a visit only if needed (“as-needed”). It may help families and clinicians see which follow-up approach works best after illnesses like pneumonia, stomach flu (gastroenteritis), skin infections, or urinary tract infections.
Plainsboro, New JerseyAges Up to 18 years - NCT06226558Recruiting
Long-Term Health of Children with Congenital CMV in NY
This study will follow children born in New York State who were tested for cytomegalovirus (CMV) as newborns. It aims to understand their long-term health and development, whether they were confirmed to have CMV, a false positive, or even a late detection if born early.
Stony Brook, New YorkAges birth–1 year
Hear when a new Infections trial opens near New York, NY
We’ll email you when one opens near New York, NY — at most once a week, no account needed, unsubscribe anytime.
Infections trials in other cities
Where these studies are running near New York
Institutions with a site for the recruiting infections studies listed above.
- New York Medical College · 5 studies
- Atlantic Health System · 2 studies
- Montefiore Medical Center · 2 studies
- Cooperman Barnabas Medical Center
- DiGiovanna Institute for Medical Education and Research
- Englewood Hospital and Medical Center
- Hackensack University Medical Center
- ID Care ( Site 1507)
What taking part in a infections study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Looking wider? See all recruiting infections studies in New York.
Common questions
- Are there infections clinical trials near New York?
- Yes. We're currently tracking 117 recruiting infections studies with a site near New York, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a infections study near New York?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in New York to take part?
- Not necessarily. These studies have a site near New York, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a infections trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New infections studies open near New York regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.